Evidence map›Paper›PMID 28870269›Full record

ArticleInfection control and hospital epidemiology2017

Failure to Communicate: Transmission of Extensively Drug-Resistant bla OXA-237-Containing Acinetobacter baumannii-Multiple Facilities in Oregon, 2012-2014.

Genevieve L Buser, P Maureen Cassidy, Margaret C Cunningham, Susan Rudin, Andrea M Hujer, Robert Vega, Jon P Furuno, Steven H Marshall, Paul G Higgins, Michael R Jacobs and 5 more

Open access · greenAbstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  3. Article
  4. Molecular Epidemiology of Carbapenem-ResistantMicrobial drug resistance (Larchmont, N.Y.) · 2022
    Article
  5. Article
  6. Article
  7. Carbapenemases: TransformingBiomolecules · 2020
    Review
  8. Article
  9. Investigation of a Carbapenemase-producingAntimicrobial resistance and infection control · 2018
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Genevieve L Buser1Public Health Division,Oregon Health Authority,Portland,Oregon.
P Maureen Cassidy1Public Health Division,Oregon Health Authority,Portland,Oregon.
Margaret C Cunningham1Public Health Division,Oregon Health Authority,Portland,Oregon.
Susan Rudin2Department of Medicine,Case Western Reserve University School of Medicine,Cleveland,Ohio.
Andrea M Hujer2Department of Medicine,Case Western Reserve University School of Medicine,Cleveland,Ohio.
Robert Vega1Public Health Division,Oregon Health Authority,Portland,Oregon.
Jon P Furuno4Department of Pharmacy Practice,Oregon State University/Oregon Health & Science University College of Pharmacy,Portland,Oregon.
Steven H Marshall2Department of Medicine,Case Western Reserve University School of Medicine,Cleveland,Ohio.
Paul G Higgins5Institute for Medical Microbiology,Immunology and Hygiene,University of Cologne,Cologne,Germany.
Michael R Jacobs7Department of Pathology,Case Western Reserve University School of Medicine,Cleveland,Ohio.
Meredith S Wright8J. Craig Venter Institute,La Jolla,California.
Mark D Adams8J. Craig Venter Institute,La Jolla,California.
Robert A Bonomo2Department of Medicine,Case Western Reserve University School of Medicine,Cleveland,Ohio.
Christopher D Pfeiffer10Department of Hospital & Specialty Medicine,VA Portland Health Care System,Portland,Oregon.
Zintars G Beldavs1Public Health Division,Oregon Health Authority,Portland,Oregon.
Oregon Health Authority · USUniversity School · USJ. Craig Venter Institute · USCase Western Reserve University · USLouis Stokes Cleveland VA Medical Center · USOregon Health & Science University · USOregon State University · USUniversity of Cologne · DE

Funding

The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7M
Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
A Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4M
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–
ACL HHS U54CK000484BLRD VA I01 BX001974NCEZID CDC HHS U54 CK000484NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS U19 AI110819
6 · The paper itself

Abstract

OBJECTIVE To determine the scope, source, and mode of transmission of a multifacility outbreak of extensively drug-resistant (XDR) Acinetobacter baumannii. DESIGN Outbreak investigation. SETTING AND PARTICIPANTS Residents and patients in skilled nursing facilities, long-term acute-care hospital, and acute-care hospitals. METHODS A case was defined as the incident isolate from clinical or surveillance cultures of XDR Acinetobacter baumannii resistant to imipenem or meropenem and nonsusceptible to all but 1 or 2 antibiotic classes in a patient in an Oregon healthcare facility during January 2012-December 2014. We queried clinical laboratories, reviewed medical records, oversaw patient and environmental surveillance surveys at 2 facilities, and recommended interventions. Pulsed-field gel electrophoresis (PFGE) and molecular analysis were performed. RESULTS We identified 21 cases, highly related by PFGE or healthcare facility exposure. Overall, 17 patients (81%) were admitted to either long-term acute-care hospital A (n=8), or skilled nursing facility A (n=8), or both (n=1) prior to XDR A. baumannii isolation. Interfacility communication of patient or resident XDR status was not performed during transfer between facilities. The rare plasmid-encoded carbapenemase gene bla OXA-237 was present in 16 outbreak isolates. Contact precautions, chlorhexidine baths, enhanced environmental cleaning, and interfacility communication were implemented for cases to halt transmission. CONCLUSIONS Interfacility transmission of XDR A. baumannii carrying the rare blaOXA-237 was facilitated by transfer of affected patients without communication to receiving facilities. Infect Control Hosp Epidemiol 2017;38:1335-1341.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAdultAgedAged, 80 and overCross InfectionDisease OutbreaksDrug Resistance, Multiple, BacterialElectrophoresis, Gel, Pulsed-FieldFemaleHumansMaleMiddle AgedMultilocus Sequence TypingOregonPolymerase Chain Reaction

Identifiers

PMID28870269
PMCPMC5783543
OpenAlexW2751955589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.